Delray Medical Center is the first hospital in South Florida to offer an innovative treatment for patients with slow or irregular heart rhythms, using the new AVEIR™ DR dual chamber leadless pacemaker system. The first surgery was performed at the hospital by Dr. Mark Freher on April 18th.
Approved by the U.S. Food and Drug Administration in June 2023, the AVEIR DR system, which is manufactured by Abbott, provides a new minimally invasive option to treat people who require pacing in two chambers of the heart (both the right atrium and right ventricle). Unlike traditional pacemakers, leadless devices are implanted directly into the heart and eliminate the need for cardiac leads. Traditional pacemakers require an incision to implant a battery in a pocket under the patient’s skin in the collarbone area. Wires from the battery are then stretched through veins and attached to the heart muscle.
“We believe offering this innovative new treatment will help improve the lives of our patients by reducing their exposure to the kinds of lead and pocket-related complications associated with traditional pacemakers,” said Daniel Listi, Delray Medical Center’s CEO. “This is another affirmation of our commitment to providing the communities we serve with groundbreaking technologies and treatments that meet the healthcare needs of residents.”
